Literature DB >> 11915918

mTOR-dependent control of skeletal muscle protein synthesis.

J C Lawrence1.   

Abstract

Muscle mass is influenced by many factors including genetically programmed changes, hormonal state, level of activity, and disease processes. Ultimately, whether or not a muscle hypertrophies or atrophies is determined by a simple relationship between the rates of protein synthesis and degradation. When synthesis exceeds degradation, the muscle hypertrophies, and vice versa. In contrast to this simple relationship, the processes that control muscle protein synthesis and degradation are complex. Recently, significant progress has been made in understanding the biochemical mechanisms that control the rate of translation initiation, which is generally the limiting phase in protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11915918     DOI: 10.1123/ijsnem.11.s1.s177

Source DB:  PubMed          Journal:  Int J Sport Nutr Exerc Metab        ISSN: 1526-484X            Impact factor:   4.599


  5 in total

1.  Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells.

Authors:  Naoya Nakai; Fuminori Kawano; Ken Nakata
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

Review 2.  Angiotensin II as candidate of cardiac cachexia.

Authors:  Patrice Delafontaine; Makoto Akao
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-05       Impact factor: 4.294

3.  RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.

Authors:  Xiaodong Mu; Ying Tang; Koji Takayama; Wanqun Chen; Aiping Lu; Bing Wang; Kurt Weiss; Johnny Huard
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

4.  Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle.

Authors:  Saman Eghtesad; Siddharth Jhunjhunwala; Steven R Little; Paula R Clemens
Journal:  Sci Rep       Date:  2012-05-08       Impact factor: 4.379

Review 5.  Sarcopenia, Frailty, and Diabetes in Older Adults.

Authors:  Hak Chul Jang
Journal:  Diabetes Metab J       Date:  2016-04-21       Impact factor: 5.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.